UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
October 31, 2014
DOLBY LABORATORIES, INC.
(Exact name of registrant as specified in its charter)
| Delaware | 001-32431 | 90-0199783 | ||
| (State or other jurisdiction of incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) |
100 Potrero Avenue
San Francisco, CA 94103-4813
(Address of principal executive offices) (Zip Code)
(415) 558-0200
(Registrant’s telephone number, including area code)
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
| ¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Section 8 – Other Events
| Item 8.01 | Other Events. |
On October 31, 2014, Dolby Laboratories, Inc. completed its acquisition of Doremi Labs. The press release announcing the completion of the transaction is attached as Exhibit 99.1.
Section 9 – Financial Statements and Exhibits
| Item 9.01 | Financial Statements and Exhibits. |
(d) Exhibits.
| Exhibit |
Description | |
| 99.1 | Press Release of Dolby Laboratories, Inc. dated November 3, 2014 | |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| DOLBY LABORATORIES, INC. | ||
| By: | /s/ ANDY SHERMAN | |
| Andy Sherman | ||
| Executive Vice President, General Counsel | ||
| and Secretary | ||
Date: November 3, 2014
EXHIBIT INDEX
| Exhibit |
Description | |
| 99.1 | Press Release of Dolby Laboratories, Inc. dated November 3, 2014 | |
Exhibit 99.1
Media Contact:
Sean Durkin
Dolby Laboratories
415-645-5176
news@dolby.com
Dolby Acquires Doremi Labs
San Francisco, November 3, 2014—Dolby Laboratories, Inc. (NYSE: DLB) has completed its acquisition of Doremi Labs. The deal advances Dolby’s mission to improve the cinema experience, enable new forms of storytelling, and accelerate the delivery and deployment of innovative solutions to exhibitors.
The acquisition establishes Dolby as a leader in audio and video playback solutions with a comprehensive product portfolio for the cinema exhibition industry.
“We are thrilled to bring together two teams that are committed to delivering the best digital cinema processing and playback solutions,” said Kevin Yeaman, President and CEO, Dolby Laboratories. “Delivering deeply integrated audio/video playback solutions will allow us to accelerate innovation and deliver amazing experiences for exhibitors and audiences.”
About Dolby Laboratories
Dolby Laboratories (NYSE: DLB) creates audio, video, and voice technologies that transform entertainment and communications in mobile devices, at the cinema, at home, and at work. For nearly 50 years, sight and sound experiences have become more vibrant, clear, and powerful in Dolby®. For more information, please visit www.dolby.com.
Dolby and the double-D symbol are registered trademarks of Dolby Laboratories. S14/28380 DLB-G